← SynDRA
CARTEOLOL
SynDRA canonical compound SYN0002149 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | glaucoma | intraocular pressure | ocular hypertension |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB1 ANTAGONIST
- Adrenergic receptor beta antagonist
- ADRB2 ANTAGONIST
- ADRB3 ANTAGONIST
- ADRB1 AGONIST
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
- C07A · BETA BLOCKING AGENTS
Cross-references
Synonyms
- dl-Carteolol
- carteolol hydrochloride
- carteolol HCl
- Carteololum
- Carteolol HCl
- Carteolol Monohydrochloride
- Arteolol (TN)
- Arteoptic (TN)
- Calte (TN)
- Carteol (TN)
- Carteolol (INN)
- Carteolol [INN:BAN]
- Carteololum [INN-Latin]
- Cartrol (TN)
- Elebloc (TN)
- Endak (TN)
- Glauteolol (TN)
- Mikelan (TN)
- Ocupress (TN)
- Poenglaucol (TN)
- Singlauc (TN)
- Teoptic (TN)
- 5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-3,4-dihydroquinolin-2(1H)-one
- 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one
- 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one
- 8NF31401XG
- CHEBI:3437
- carteololo
- RefChem:58563
- DTXCID202746
- C07AA15
- S01ED05
- CARTEOLOL [INN]
- UNII-8NF31401XG
- CARTEOLOL [JAN]
- CARTEOLOL [MI]
- Prestwick0_000446
- Prestwick1_000446
Reported adverse events
- Arrhythmia
- Bronchospasm
- Depression
- Headache
- Hypersensitivity
- Nausea
Look up CARTEOLOL in the interactive SynDRA portal →